The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy

Citation
T. Olivry et Ca. Sousa, The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy, VET IMMUNOL, 81(3-4), 2001, pp. 317-322
Citations number
25
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
ISSN journal
01652427 → ACNP
Volume
81
Issue
3-4
Year of publication
2001
Pages
317 - 322
Database
ISI
SICI code
0165-2427(20010920)81:3-4<317:TATFOC>2.0.ZU;2-8
Abstract
Glucocorticoids (GCs) have been the most commonly prescribed drugs for trea tment of canine atopic dermatitis (AD) during the last decades. In spite of this widespread usage, there are a few studies documenting their efficacy. Fortunately, recently completed clinical. trials were designed with oral G Cs used as "standard of care" for treatment of canine AD. These studies pro vided high quality evidence in favor of the strong efficacy of oral low-dos e glucocorticoid formulations to control skin lesions and pruritus in dogs with AD. Consequently, there is good evidence to support the recommendation of use of oral glucocorticoids for treatment of canine AD. (C) 2001 Elsevi er Science B.V. All rights reserved.